NCT06646224View on ClinicalTrials.gov

Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 12, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Cardiogenic Shock
Interventions
DEVICE

CorVad Percutaneous Ventricular Assist System

The CorVad Percutaneous Ventricular Assist System provides circulatory support for patients with cardiogenic shock.

Trial Locations (1)

Unknown

RECRUITING

Fuwai Hospital Chinese Academy of Medical Sciences.Shenzhen, Shenzhen

All Listed Sponsors
lead

Shenzhen Core Medical Technology CO.,LTD.

INDUSTRY